Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Aspergillosis × Micafungin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Leukemia 1 Invasive Fungal Infections 1 Hematologic Neoplasms 1 Febrile Neutropenia 1 Aspergillosis 1

Interventions

posaconazole 1 liposomal amphotericin B 1 Voriconazole 1 Micafungin 1 Fluconazole 1 Blood Specimen Collection 1 Amphotericin B 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01207128 2012-04-20

Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis

University of Arkansas

Phase 2 Withdrawn

Aspergillosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡